Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN - DE000BAY0017 - Common Stock

28.415 EUR
+0.24 (+0.87%)
Last: 9/8/2025, 7:00:00 PM
Fundamental Rating

3

1BAYN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 50 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year 1BAYN was profitable.
In the past year 1BAYN had a positive cash flow from operations.
In multiple years 1BAYN reported negative net income over the last 5 years.
Each year in the past 5 years 1BAYN had a positive operating cash flow.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

1BAYN has a worse Return On Assets (-3.25%) than 70.00% of its industry peers.
With a Return On Equity value of -11.25%, 1BAYN is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.25%
ROE -11.25%
ROIC N/A
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of 1BAYN has declined.
1BAYN has a Gross Margin of 54.95%. This is in the lower half of the industry: 1BAYN underperforms 70.00% of its industry peers.
In the last couple of years the Gross Margin of 1BAYN has declined.
The Profit Margin and Operating Margin are not available for 1BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
The number of shares outstanding for 1BAYN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, 1BAYN has an improved debt to assets ratio.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1BAYN has an Altman-Z score of 0.79. This is a bad value and indicates that 1BAYN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of 1BAYN (0.79) is worse than 70.00% of its industry peers.
The Debt to FCF ratio of 1BAYN is 8.37, which is on the high side as it means it would take 1BAYN, 8.37 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.37, 1BAYN is doing worse than 60.00% of the companies in the same industry.
A Debt/Equity ratio of 1.04 is on the high side and indicates that 1BAYN has dependencies on debt financing.
1BAYN has a Debt to Equity ratio of 1.04. This is in the lower half of the industry: 1BAYN underperforms 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 8.37
Altman-Z 0.79
ROIC/WACCN/A
WACC6.25%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.13 indicates that 1BAYN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.13, 1BAYN is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.73 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN's Quick ratio of 0.73 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.73
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for 1BAYN have decreased strongly by -16.36% in the last year.
Measured over the past years, 1BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
Looking at the last year, 1BAYN shows a decrease in Revenue. The Revenue has decreased by -1.99% in the last year.
Measured over the past years, 1BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%

3.2 Future

The Earnings Per Share is expected to grow by 3.05% on average over the next years.
The Revenue is expected to grow by 1.19% on average over the next years.
EPS Next Y-6.48%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
EPS Next 5Y3.05%
Revenue Next Year-1.14%
Revenue Next 2Y-0.12%
Revenue Next 3Y0.7%
Revenue Next 5Y1.19%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.67, the valuation of 1BAYN can be described as very cheap.
94.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.07. 1BAYN is valued rather cheaply when compared to this.
1BAYN is valuated cheaply with a Price/Forward Earnings ratio of 5.80.
96.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Forward Earnings ratio.
1BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.59.
Industry RankSector Rank
PE 5.67
Fwd PE 5.8
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1BAYN is valued a bit cheaper than 70.00% of the companies in the same industry.
1BAYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 98.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.08
EV/EBITDA 9.05
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.54%
EPS Next 3Y2.06%

More info and screens

0

5. Dividend

5.1 Amount

1BAYN has a yearly dividend return of 0.38%, which is pretty low.
1BAYN's Dividend Yield is slightly below the industry average, which is at 3.06.
Compared to an average S&P500 Dividend Yield of 2.46, 1BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (9/8/2025, 7:00:00 PM)

28.415

+0.24 (+0.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-06 2025-08-06/dmh
Earnings (Next)11-12 2025-11-12
Inst Owners41.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.92B
Analysts71.43
Price Target29.04 (2.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)0.69%
PT rev (3m)5.66%
EPS NQ rev (1m)-3.01%
EPS NQ rev (3m)19.4%
EPS NY rev (1m)2.38%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)-3.39%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-1.01%
Valuation
Industry RankSector Rank
PE 5.67
Fwd PE 5.8
P/S 0.6
P/FCF 6.08
P/OCF 3.9
P/B 0.92
P/tB N/A
EV/EBITDA 9.05
EPS(TTM)5.01
EY17.63%
EPS(NY)4.9
Fwd EY17.23%
FCF(TTM)4.67
FCFY16.45%
OCF(TTM)7.28
OCFY25.61%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.25%
ROE -11.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM 9.94%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 8.37
Debt/EBITDA 4.79
Cap/Depr 32.07%
Cap/Sales 5.54%
Interest Coverage N/A
Cash Conversion 107.94%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.73
Altman-Z 0.79
F-Score4
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
EPS Next Y-6.48%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
EPS Next 5Y3.05%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
Revenue Next Year-1.14%
Revenue Next 2Y-0.12%
Revenue Next 3Y0.7%
Revenue Next 5Y1.19%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.3%
EBIT Next 3Y21.17%
EBIT Next 5Y10.79%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%